UnknownNot Applicable

Efficacy and Central Mechanism of Acupuncture for Treating Chronic Subjective Tinnitus Assessed by fNIRS

China60 participantsStarted 2023-05

Plain-language summary

This randomized controlled pilot trial aims to explore the Efficacy and central mechanism of acupuncture for treating chronic subjective tinnitus using functional near-infrared spectroscopy (fNIRS).

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Bilateral tinnitus that meets the diagnostic criteria for chronic subjective tinnitus.
✓. Male and female, Aged between 18 and 60 years.
✓. Participants can cooperate with experimental procedures and sign written inform consent.
✓. Not participating in other clinical trials concurrently.

Exclusion criteria

✕. Participants with objective tinnitus
✕. Participants have nervous system diseases or neuropsychiatric diseases that can significantly affect brain blood oxygen metabolism assessed by resting-state functional connectivity.
✕. Participants with severe cardiovascular and cerebrovascular diseases, malignant liver and kidney diseases, and other serious diseases.
✕. Participants have any contraindications for acupuncture (such as a bleeding tendency)
✕. Pregnant or lactating women.
✕. Participants have received tinnitus treatment with drugs or other therapies in the last four weeks.

What they're measuring

Change in resting-state functional connectivity (RSFC)

Timeframe: at baseline (pre-treatment), at 4 weeks after intervention, at 3-month follow-up

Change in hemoglobin signals

Timeframe: at baseline (pre-treatment), at 4 weeks after intervention, at 3-month follow-up

Trial details

NCT IDNCT05829278

SponsorThe Third Affiliated hospital of Zhejiang Chinese Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12

Contact for this trial

Xiaoqi Lin, M.M

15017541801 linxq361@163.com

View on ClinicalTrials.gov More Tinnitus trials